U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07869186) titled 'Dermatological Effects and Quality of Life in Oncology Patients' on Oct. 06.
Brief Summary: This is a monocentric, low-risk interventional study designed to characterize established treatment-related dermatologic toxicity in patients receiving systemic anticancer therapies. The study will not modify or influence oncologic treatment decisions but will perform standardized instrumental and clinical dermatologic assessments during the course of routine cancer care.
Study Start Date: Oct. 12
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Ovarian Cancer
NSCLC (Non-small Cell Lung Cancer)
Melanoma (Skin Cancer)
Gynecological Canc...